Dean Tsarwhas

Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer

Ami N. Shah, Lisa Flaum, Irene Helenowski et al. · Journal for ImmunoTherapy of Cancer · 2020 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial

Chadi Nabhan, Timothy M. Lestingi, Ángel Gálvez et al. · Urology · 2009 · 54 citations

Medicine, Oncology, Urology +14

Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience

Lorenzo Gerratana, Michael Movarek, Firas Wehbe et al. · JCO Precision Oncology · 2022 · 25 citations

Medicine, Molecular Genetics, Oncology +17

A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases

Ami N. Shah, Cesar A. Santa‐Maria, Dhruvika Mukhija et al. · Clinical Breast Cancer · 2022 · 14 citations

Medicine, Oncology, Pharmacology +17

Web-Based Cancer Symptom Self-Management System

David Cella, Nicola Lancki, Maja Kuharić et al. · JAMA Network Open · 2025 · 11 citations · Full text

Nursing, Health Informatics, Oncology +17